Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1061 entries
Sorted by: Best Match Show Resources per page
Overcoming the challenges in K-12 STEM education

K-12 STEM training

Barada H, Zaki R.
GSID: NC_4t8nisgMJ
S Alyammahi, R Zaki, H Barada… - 2016 IEEE Global …, 2016 - ieeexplore.ieee.org

… by the authors, given to STEM tracN teachers in grades K-12 in the public and private … training and proper implementation are mandatory to maNe campus technology useful for STEM …

Cite
Alyammahi, S., Zaki, R., Barada, H., & Al-Hammadi, Y. (2016, April). Overcoming the challenges in K-12 STEM education. In 2016 IEEE Global Engineering Education Conference (EDUCON) (pp. 951-960). IEEE.
Alyammahi, Sohailah, et al. "Overcoming the challenges in K-12 STEM education." 2016 IEEE Global Engineering Education Conference (EDUCON). IEEE, 2016.
Copy Download .nbib Format: MLA
[Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety].

Kangogaku zasshi

Kamimura M, Ishinabe K, Katada M, Kinoshita Y, Kuwano T.
PMID: 4995178
Kangogaku Zasshi. 1971 Apr;35(4):15-8.

No abstract available.

Cite
Kamimura M, Ishinabe K, Katada M, et al. [Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]. Kangogaku Zasshi. 1971;35(4):15-8
Kamimura, M., Ishinabe, K., Katada, M., Kinoshita, Y., & Kuwano, T. (1971). [Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]. Kangogaku zasshi, 35(4), 15-8.
Kamimura, M, et al. "[Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]." Kangogaku zasshi vol. 35,4 (1971): 15-8.
Kamimura M, Ishinabe K, Katada M, Kinoshita Y, Kuwano T. [Orientation at the time of hospital admission. 2. Orientation of patients to ease their anxiety]. Kangogaku Zasshi. 1971 Apr;35(4):15-8. Japanese. PMID: 4995178.
Copy Download .nbib Format: NLM
[Methods of nursing care in internal medicine].

Kango kyoshitsu. [Nursing classroom]

Kawada H.
PMID: 5186578
Kango Kyoshitsu. 1967 Dec;11(13):12-5.

No abstract available.

Cite
Kawada H. [Methods of nursing care in internal medicine]. Kango Kyoshitsu. 1967;11(13):12-5
Kawada, H. (1967). [Methods of nursing care in internal medicine]. Kango kyoshitsu. [Nursing classroom], 11(13), 12-5.
Kawada, H. "[Methods of nursing care in internal medicine]." Kango kyoshitsu. [Nursing classroom] vol. 11,13 (1967): 12-5.
Kawada H. [Methods of nursing care in internal medicine]. Kango Kyoshitsu. 1967 Dec;11(13):12-5. Japanese. PMID: 5186578.
Copy Download .nbib Format: NLM
Treatment outcomes of carotid artery stenting with two types of distal protection filter device.

SpringerPlus

Iko M, Aikawa H, Go Y, Nakai K, Tsutsumi M, Yu I, Mizokami T, Sakamoto K, Inoue R, Mitsutake T, Eto A, Hanada H, Kazekawa K.
PMID: 25674435
Springerplus. 2014 Mar 08;3:132. doi: 10.1186/2193-1801-3-132. eCollection 2014.

PURPOSE: Preventing cerebral embolism from debris produced during carotid artery stenting (CAS) is important. This study compared the treatment outcomes of CAS using two types of filter-based embolic protection devices currently in use in Japan.MATERIALS AND METHODS: We assessed...

Cite
Iko M, Aikawa H, Go Y, et al. Treatment outcomes of carotid artery stenting with two types of distal protection filter device. Springerplus. 2014;3:132doi: 10.1186/2193-1801-3-132.
Iko, M., Aikawa, H., Go, Y., Nakai, K., Tsutsumi, M., Yu, I., Mizokami, T., Sakamoto, K., Inoue, R., Mitsutake, T., Eto, A., Hanada, H., & Kazekawa, K. (2014). Treatment outcomes of carotid artery stenting with two types of distal protection filter device. SpringerPlus, 3132. https://doi.org/10.1186/2193-1801-3-132
Iko, Minoru, et al. "Treatment outcomes of carotid artery stenting with two types of distal protection filter device." SpringerPlus vol. 3 (2014): 132. doi: https://doi.org/10.1186/2193-1801-3-132
Iko M, Aikawa H, Go Y, Nakai K, Tsutsumi M, Yu I, Mizokami T, Sakamoto K, Inoue R, Mitsutake T, Eto A, Hanada H, Kazekawa K. Treatment outcomes of carotid artery stenting with two types of distal protection filter device. Springerplus. 2014 Mar 08;3:132. doi: 10.1186/2193-1801-3-132. eCollection 2014. PMID: 25674435; PMCID: PMC4320198.
Copy Download .nbib Format: NLM
The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber.

Journal of drug assessment

Hashiguchi K, Okubo K, Wakabayashi K, Tanaka N, Watada Y, Suematsu K, Gotoh M.
PMID: 27536427
J Drug Assess. 2012 Oct 09;1(1):40-7. doi: 10.3109/21556660.2012.728547. eCollection 2012.

OBJECTIVE: The study objective was to investigate the prophylactic efficacy of montelukast (MLK) 10 mg in suppressing seasonal allergic rhinitis (SAR) symptoms induced by Japanese cedar (JC) pollen and to determine how many days before exposure to JC in...

Cite
Hashiguchi K, Okubo K, Wakabayashi K, et al. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber. J Drug Assess. 2012;1(1):40-7doi: 10.3109/21556660.2012.728547.
Hashiguchi, K., Okubo, K., Wakabayashi, K., Tanaka, N., Watada, Y., Suematsu, K., & Gotoh, M. (2012). The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber. Journal of drug assessment, 1(1), 40-7. https://doi.org/10.3109/21556660.2012.728547
Hashiguchi, Kazuhiro, et al. "The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber." Journal of drug assessment vol. 1,1 (2012): 40-7. doi: https://doi.org/10.3109/21556660.2012.728547
Hashiguchi K, Okubo K, Wakabayashi K, Tanaka N, Watada Y, Suematsu K, Gotoh M. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber. J Drug Assess. 2012 Oct 09;1(1):40-7. doi: 10.3109/21556660.2012.728547. eCollection 2012. PMID: 27536427; PMCID: PMC4980728.
Copy Download .nbib Format: NLM
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I.
PMID: 28864997
Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01.

INTRODUCTION: Sodium-glucose co-transporter-2 (SGLT2) inhibitors are anti-diabetic agents that improve glycemic control with a low risk of hypoglycemia and ameliorate a variety of cardiovascular risk factors. The aim of the ongoing study described herein is to investigate the preventive...

Cite
Katakami N, Mita T, Yoshii H, et al. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017;8(5):999-1013doi: 10.1007/s13300-017-0292-1.
Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., Umayahara, Y., Kaneto, H., Osonoi, T., Yamamoto, T., Kuribayashi, N., Maeda, K., Yokoyama, H., Kosugi, K., Ohtoshi, K., Hayashi, I., Sumitani, S., Tsugawa, M., Ohashi, M., Taki, H., Nakamura, T., Kawashima, S., Sato, Y., Watada, H., Shimomura, I. (2017). Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(5), 999-1013. https://doi.org/10.1007/s13300-017-0292-1
Katakami, Naoto, et al. "Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,5 (2017): 999-1013. doi: https://doi.org/10.1007/s13300-017-0292-1
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01. PMID: 28864997; PMCID: PMC5630549.
Copy Download .nbib Format: NLM
Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice.

International journal of endocrinology

Nakajima K, Mita T, Osonoi Y, Azuma K, Takasu T, Fujitani Y, Watada H.
PMID: 26366172
Int J Endocrinol. 2015;2015:406394. doi: 10.1155/2015/406394. Epub 2015 Aug 20.

Epidemiological data suggest that postprandial hyperglycaemia and hypoglycaemia are potential risk factors for cardiovascular disease. However, the effects of repetitive postprandial glucose spikes, repetitive hypoglycaemia, and their combination on the progression of atherosclerosis remain largely unknown. The present study...

Cite
Nakajima K, Mita T, Osonoi Y, et al. Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice. Int J Endocrinol. 2015;2015:406394doi: 10.1155/2015/406394.
Nakajima, K., Mita, T., Osonoi, Y., Azuma, K., Takasu, T., Fujitani, Y., & Watada, H. (2015). Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice. International journal of endocrinology, 2015406394. https://doi.org/10.1155/2015/406394
Nakajima, Kenichi, et al. "Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice." International journal of endocrinology vol. 2015 (2015): 406394. doi: https://doi.org/10.1155/2015/406394
Nakajima K, Mita T, Osonoi Y, Azuma K, Takasu T, Fujitani Y, Watada H. Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice. Int J Endocrinol. 2015;2015:406394. doi: 10.1155/2015/406394. Epub 2015 Aug 20. PMID: 26366172; PMCID: PMC4558450.
Copy Download .nbib Format: NLM
Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?.

Endoscopy international open

Ono S, Myojo M, Harada H, Tsuji K, Murakami D, Suehiro S, Doyama H, Ando J, Saito I, Fujishiro M, Komuro I, Koike K.
PMID: 28924604
Endosc Int Open. 2017 Sep;5(9):E943-E949. doi: 10.1055/s-0043-116381. Epub 2017 Sep 13.

BACKGROUND AND STUDY AIMS : Combined use of thienopyridine derivatives and other antithrombotic agents is reported to be a risk factor for postoperative bleeding after gastric endoscopic submucosal dissection (ESD). However, risk associated with a single thienopyridine derivative has...

Cite
Ono S, Myojo M, Harada H, et al. Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?. Endosc Int Open. 2017;5(9):E943-E949doi: 10.1055/s-0043-116381.
Ono, S., Myojo, M., Harada, H., Tsuji, K., Murakami, D., Suehiro, S., Doyama, H., Ando, J., Saito, I., Fujishiro, M., Komuro, I., & Koike, K. (2017). Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?. Endoscopy international open, 5(9), E943-E949. https://doi.org/10.1055/s-0043-116381
Ono, Satoshi, et al. "Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?." Endoscopy international open vol. 5,9 (2017): E943-E949. doi: https://doi.org/10.1055/s-0043-116381
Ono S, Myojo M, Harada H, Tsuji K, Murakami D, Suehiro S, Doyama H, Ando J, Saito I, Fujishiro M, Komuro I, Koike K. Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives?. Endosc Int Open. 2017 Sep;5(9):E943-E949. doi: 10.1055/s-0043-116381. Epub 2017 Sep 13. PMID: 28924604; PMCID: PMC5597936.
Copy Download .nbib Format: NLM
Capturing local structure modulations of photoexcited BiVO.

Chemical communications (Cambridge, England)

Uemura Y, Kido D, Koide A, Wakisaka Y, Niwa Y, Nozawa S, Ichiyanagi K, Fukaya R, Adachi SI, Katayama T, Togashi T, Owada S, Yabashi M, Hatada K, Iwase A, Kudo A, Takakusagi S, Yokoyama T, Asakura K.
PMID: 28480915
Chem Commun (Camb). 2017 Jun 29;53(53):7314-7317. doi: 10.1039/c7cc02201h.

Ultrafast excitation of photocatalytically active BiVO

Cite
Uemura Y, Kido D, Koide A, et al. Capturing local structure modulations of photoexcited BiVO. Chem Commun (Camb). 2017;53(53):7314-7317doi: 10.1039/c7cc02201h.
Uemura, Y., Kido, D., Koide, A., Wakisaka, Y., Niwa, Y., Nozawa, S., Ichiyanagi, K., Fukaya, R., Adachi, S. I., Katayama, T., Togashi, T., Owada, S., Yabashi, M., Hatada, K., Iwase, A., Kudo, A., Takakusagi, S., Yokoyama, T., & Asakura, K. (2017). Capturing local structure modulations of photoexcited BiVO. Chemical communications (Cambridge, England), 53(53), 7314-7317. https://doi.org/10.1039/c7cc02201h
Uemura, Yohei, et al. "Capturing local structure modulations of photoexcited BiVO." Chemical communications (Cambridge, England) vol. 53,53 (2017): 7314-7317. doi: https://doi.org/10.1039/c7cc02201h
Uemura Y, Kido D, Koide A, Wakisaka Y, Niwa Y, Nozawa S, Ichiyanagi K, Fukaya R, Adachi SI, Katayama T, Togashi T, Owada S, Yabashi M, Hatada K, Iwase A, Kudo A, Takakusagi S, Yokoyama T, Asakura K. Capturing local structure modulations of photoexcited BiVO. Chem Commun (Camb). 2017 Jun 29;53(53):7314-7317. doi: 10.1039/c7cc02201h. PMID: 28480915.
Copy Download .nbib Format: NLM
Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency.

Nanomaterials (Basel, Switzerland)

Shigehiro T, Masuda J, Saito S, Khayrani AC, Jinno K, Seno A, Vaidyanath A, Mizutani A, Kasai T, Murakami H, Satoh A, Ito T, Hamada H, Seno Y, Mandai T, Seno M.
PMID: 28946623
Nanomaterials (Basel). 2017 Sep 23;7(10). doi: 10.3390/nano7100290.

Taxanes including paclitaxel and docetaxel are effective anticancer agents preferably sufficient for liposomal drug delivery. However, the encapsulation of these drugs with effective amounts into conventional liposomes is difficult due to their high hydrophobicity. Therefore, an effective encapsulation strategy...

Cite
Shigehiro T, Masuda J, Saito S, et al. Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency. Nanomaterials (Basel). 2017;7(10)doi: 10.3390/nano7100290.
Shigehiro, T., Masuda, J., Saito, S., Khayrani, A. C., Jinno, K., Seno, A., Vaidyanath, A., Mizutani, A., Kasai, T., Murakami, H., Satoh, A., Ito, T., Hamada, H., Seno, Y., Mandai, T., & Seno, M. (2017). Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency. Nanomaterials (Basel, Switzerland), 7(10), . https://doi.org/10.3390/nano7100290
Shigehiro, Tsukasa, et al. "Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency." Nanomaterials (Basel, Switzerland) vol. 7,10 (2017). doi: https://doi.org/10.3390/nano7100290
Shigehiro T, Masuda J, Saito S, Khayrani AC, Jinno K, Seno A, Vaidyanath A, Mizutani A, Kasai T, Murakami H, Satoh A, Ito T, Hamada H, Seno Y, Mandai T, Seno M. Practical Liposomal Formulation for Taxanes with Polyethoxylated Castor Oil and Ethanol with Complete Encapsulation Efficiency and High Loading Efficiency. Nanomaterials (Basel). 2017 Sep 23;7(10). doi: 10.3390/nano7100290. PMID: 28946623; PMCID: PMC5666455.
Copy Download .nbib Format: NLM
Primary Diffuse Large B-cell Lymphoma Arising in the Tongue Accompanied by Ataxia-telangiectasia: A Case Report.

Journal of clinical and diagnostic research : JCDR

Tomioka H, Kaneoya A, Mochizuki Y, Harada H.
PMID: 26266230
J Clin Diagn Res. 2015 Jun;9(6):ZD25-7. doi: 10.7860/JCDR/2015/12121.6107. Epub 2015 Jun 01.

Ataxia-telangiectasia (AT) is a rare autosomal recessive disorder that is characterized by progressive cerebellar ataxia, telangiectasia, immunodeficiency, and a predisposition to leukemia/lymphoma. Here we report a rare case of lymphoma of the tongue accompanied by AT. Tumour extirpation was...

Cite
Tomioka H, Kaneoya A, Mochizuki Y, et al. Primary Diffuse Large B-cell Lymphoma Arising in the Tongue Accompanied by Ataxia-telangiectasia: A Case Report. J Clin Diagn Res. 2015;9(6):ZD25-7doi: 10.7860/JCDR/2015/12121.6107.
Tomioka, H., Kaneoya, A., Mochizuki, Y., & Harada, H. (2015). Primary Diffuse Large B-cell Lymphoma Arising in the Tongue Accompanied by Ataxia-telangiectasia: A Case Report. Journal of clinical and diagnostic research : JCDR, 9(6), ZD25-7. https://doi.org/10.7860/JCDR/2015/12121.6107
Tomioka, Hirofumi, et al. "Primary Diffuse Large B-cell Lymphoma Arising in the Tongue Accompanied by Ataxia-telangiectasia: A Case Report." Journal of clinical and diagnostic research : JCDR vol. 9,6 (2015): ZD25-7. doi: https://doi.org/10.7860/JCDR/2015/12121.6107
Tomioka H, Kaneoya A, Mochizuki Y, Harada H. Primary Diffuse Large B-cell Lymphoma Arising in the Tongue Accompanied by Ataxia-telangiectasia: A Case Report. J Clin Diagn Res. 2015 Jun;9(6):ZD25-7. doi: 10.7860/JCDR/2015/12121.6107. Epub 2015 Jun 01. PMID: 26266230; PMCID: PMC4525621.
Copy Download .nbib Format: NLM
Four hepatosplenic T-cell lymphoma cases of Japanese patients.

Leukemia research reports

Kawai H, Matsushita H, Ohmachi K, Kojima M, Machida S, Ogawa Y, Kawada H, Nakamura N, Ando K.
PMID: 26870659
Leuk Res Rep. 2015 Dec 15;5:3-6. doi: 10.1016/j.lrr.2015.12.001. eCollection 2016.

Hepatosplenic T-cell lymphoma (HSTCL), a rare type of γδ T-cell lymphoma, is characterized by hepatosplenomegaly and cytopenias. It is associated with immunodeficiency and its age of onset is reportedly between the 20s and 30s. We herein report 4 Japanese...

Cite
Kawai H, Matsushita H, Ohmachi K, et al. Four hepatosplenic T-cell lymphoma cases of Japanese patients. Leuk Res Rep. 2015;5:3-6doi: 10.1016/j.lrr.2015.12.001.
Kawai, H., Matsushita, H., Ohmachi, K., Kojima, M., Machida, S., Ogawa, Y., Kawada, H., Nakamura, N., & Ando, K. (2016). Four hepatosplenic T-cell lymphoma cases of Japanese patients. Leukemia research reports, 53-6. https://doi.org/10.1016/j.lrr.2015.12.001
Kawai, Hidetsugu, et al. "Four hepatosplenic T-cell lymphoma cases of Japanese patients." Leukemia research reports vol. 5 (2016): 3-6. doi: https://doi.org/10.1016/j.lrr.2015.12.001
Kawai H, Matsushita H, Ohmachi K, Kojima M, Machida S, Ogawa Y, Kawada H, Nakamura N, Ando K. Four hepatosplenic T-cell lymphoma cases of Japanese patients. Leuk Res Rep. 2015 Dec 15;5:3-6. doi: 10.1016/j.lrr.2015.12.001. eCollection 2016. PMID: 26870659; PMCID: PMC4711307.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1061 entries